Skip to main content
Log in

High prevalence of activated protein C resistance in patients with systemic sclerosis

  • Letter to the Editor
  • Published:
International Journal of Clinical and Laboratory Research

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Black CM, Stephens C. Systemic sclerosis (scleroderma) and related disorders. In: Maddison PY, Isenberg DA, Woo P, Glass DN (eds.) Oxford textbook of rheumatology Oxford: Oxford University Press; 1993: 771–789.

    Google Scholar 

  2. Goodfield MJD, Orchard MA, Rowell NR. Whole platelet aggregation and coagulation factors in patients with systemic sclerosis. Br J Haematol 1993; 84: 675.

    PubMed  CAS  Google Scholar 

  3. Holland CD, Jayson MIV. Venous blood fibrinolysis and fibronolytic potential in primary Raynaud's phenomenon and systemic sclerosis associated Raynaud's phenomenon. In: Black CM, Mayers AM (eds) Current topics in rheumatology. Progressive systemic sclerosis. New York: Gower; 1985: 267–273.

    Google Scholar 

  4. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor response to activated protein. C. Proc Natl Acad Sci USA 1993; 90: 1004.

    Article  CAS  Google Scholar 

  5. Dahlback B. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene. Haemostasis 1994; 24: 139.

    PubMed  CAS  Google Scholar 

  6. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581.

    Article  Google Scholar 

  7. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, Ronde H de, Der Velden PA van, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64.

    Article  PubMed  CAS  Google Scholar 

  8. Halbmayer WM, Haushofer A, Schon R, Fischer M. Influence of lupus anticoagulant on a commercially available kit for APC-resistance. Thromb Haemost 1994; 72: 643.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Lucia, D., De Blasio, G., Belli, A. et al. High prevalence of activated protein C resistance in patients with systemic sclerosis. Int J Clin Lab Res 25, 226–227 (1995). https://doi.org/10.1007/BF02592703

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02592703

Key words

Navigation